4//SEC Filing
Tolf Bo-Ragnar 4
Accession 0001181431-09-034837
CIK 0001070494other
Filed
Jul 8, 8:00 PM ET
Accepted
Jul 9, 4:39 PM ET
Size
10.6 KB
Accession
0001181431-09-034837
Insider Transaction Report
Form 4
Tolf Bo-Ragnar
VP/Mg. Dir. ACADIA Pharma AB
Transactions
- Exercise/Conversion
Stock Option (right to buy)
2009-07-08−10,000→ 15,000 totalExercise: $1.08Exp: 2013-09-07→ Common Stock (10,000 underlying) - Exercise/Conversion
Common Stock
2009-07-08$1.08/sh+10,000$10,800→ 10,000 total - Exercise/Conversion
Common Stock
2009-07-08$1.08/sh+10,000$10,800→ 20,000 total - Exercise/Conversion
Stock Option (right to buy)
2009-07-08−10,000→ 0 totalExercise: $1.08Exp: 2013-03-16→ Common Stock (10,000 underlying)
Footnotes (2)
- [F1]25% of the shares subject to the Stock Option vested and became exercisable on March 17, 2004. The remaining shares vested and became exercisable thereafter in 36 equal monthly installments.
- [F2]25% of the shares subject to the Stock Option vested and became exercisable on September 8, 2004. The remaining shares vested and became exercisable thereafter in 36 equal monthly installments.
Documents
Issuer
ACADIA PHARMACEUTICALS INC
CIK 0001070494
Entity typeother
Related Parties
1- filerCIK 0001291967
Filing Metadata
- Form type
- 4
- Filed
- Jul 8, 8:00 PM ET
- Accepted
- Jul 9, 4:39 PM ET
- Size
- 10.6 KB